Oral versus intravenous steroids for treatment of relapses in multiple sclerosis - Burton, JM -
2012 | Cochrane Library … Jodie M Burton … Odds Ratio (M‐H, Random, 95% CI) …

Background: There is a role for brief assessment instruments in detection and management
of major depression in MS. However, candidate scales have rarely been validated against a …

Background The prevalence of anxiety and its association with sociodemographic and
clinical factors is not well characterized in those with multiple sclerosis (MS). We aimed to …

Multiple sclerosis (MS) is a progressive neurological disorder characterized by both inflammatory
and degenerative components that affect genetically susceptible individuals. Currently, …

Context: The active metabolite of vitamin D, 1,25-dihydroxyvitamin D [1,25(OH) 2 D], is a potent
modulator of immune cells in vitro. Objective: Our objective was to determine whether the …

Background In this prospective case series, we aimed to characterise the temporal evolution
of functional and structural measures in the afferent visual pathway of patients with acute …

Background: It has been proposed by Zamboni and colleagues that multiple sclerosis is
caused by chronic cerebrospinal venous insufficiency, a term used to describe ultrasound-…

Background:Over the past four years, West Nile virus (WNV) has become a significant health
issue in North America. In 2002, WNV infection made its first appearance in the human …

In this topical review, we discuss the history of the area postrema syndrome, with special
attention given to early studies aimed at identifying the area postrema and its function, possible …

Background: Vitamin D sufficiency is associated with better inflammatory outcomes in
multiple sclerosis (MS). We hypothesize that it is also associated with better long-term …